Intellia Therapeutics NTLA Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's accounts payable?
- Intellia Therapeutics (NTLA) reported accounts payable of $18.8M in Q1 2026.
- How has Intellia Therapeutics's accounts payable changed year-over-year?
- Intellia Therapeutics's accounts payable increased by 52.1% year-over-year, from $12.36M to $18.8M.
- What is the long-term trend for Intellia Therapeutics's accounts payable?
- Over 5 years (2020 to 2025), Intellia Therapeutics's accounts payable has grown at a 14.1% compound annual growth rate (CAGR), from $10.46M to $20.25M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.